Hologic/$HOLX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Hologic

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Ticker

$HOLX
Primary listing

Industry

Health Care Equipment & Supplies

Employees

7,063

ISIN

US4364401012

Hologic Metrics

BasicAdvanced
$14B
26.76
$2.39
0.55
-

What the Analysts think about Hologic

Analyst ratings (Buy, Hold, Sell) for Hologic stock.

Bulls say / Bears say

Hologic's adjusted operating margin expanded by 170 basis points to 28.3% in the fiscal fourth quarter, driven by higher revenues and improved operating leverage. (TradingView News)
The company reported a robust free cash flow of $1.14 billion in the trailing twelve months, indicating strong operational efficiency and financial health. (TipRanks)
Hologic's debt-to-equity ratio is low at 0.01, showcasing prudent financial management and a healthy balance sheet. (TipRanks)
Hologic's stock reached a 52-week low of $70.5 amid market shifts, reflecting investor concerns over its performance. (Investing.com)
The company reported a quarterly loss of $17.4 million for the quarter ended March 31, indicating potential financial challenges. (TradingView News)
Analysts at Leerink Partners reduced their Q3 2025 earnings estimates for Hologic, reflecting a bearish outlook on the company's near-term financial performance. (Defense World)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.

Hologic Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Hologic Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HOLX

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs